Is Bristol-Myers Squibb Company Ce overvalued?

Bristol-Myers Squibb Company Ce (CELG-RI) — key valuation metrics and fundamentals.

No verdict

Price

$0.12

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$110.83B

Dividend yield

4.0%

Return on equity

43.9%

Sector

Healthcare

Fair value compares CELG-RI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks